Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of lipoprotein metabolic process (GO:0050746) | 6.44951664 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.26543289 |
3 | vitamin A metabolic process (GO:0006776) | 5.80598454 |
4 | high-density lipoprotein particle remodeling (GO:0034375) | 5.66015836 |
5 | polyol transport (GO:0015791) | 5.34544697 |
6 | regulation of triglyceride catabolic process (GO:0010896) | 5.19832942 |
7 | diterpenoid biosynthetic process (GO:0016102) | 5.07366461 |
8 | reverse cholesterol transport (GO:0043691) | 4.98639138 |
9 | phospholipid efflux (GO:0033700) | 4.96580095 |
10 | regulation of hippo signaling (GO:0035330) | 4.87182544 |
11 | cullin deneddylation (GO:0010388) | 4.71071646 |
12 | RNA-dependent DNA replication (GO:0006278) | 4.65496881 |
13 | telomere maintenance via telomerase (GO:0007004) | 4.46056928 |
14 | protein deneddylation (GO:0000338) | 4.26380392 |
15 | sleep (GO:0030431) | 4.25975322 |
16 | righting reflex (GO:0060013) | 4.17151286 |
17 | transepithelial transport (GO:0070633) | 4.16616423 |
18 | neutrophil activation involved in immune response (GO:0002283) | 4.08581414 |
19 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.07165814 |
20 | ER overload response (GO:0006983) | 4.02658492 |
21 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.98746536 |
22 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.98437110 |
23 | response to misfolded protein (GO:0051788) | 3.94988141 |
24 | negative regulation of lipase activity (GO:0060192) | 3.89812230 |
25 | plasma lipoprotein particle assembly (GO:0034377) | 3.87958795 |
26 | cholesterol efflux (GO:0033344) | 3.87279294 |
27 | negative chemotaxis (GO:0050919) | 3.77587686 |
28 | regulation of activation of Janus kinase activity (GO:0010533) | 3.73697318 |
29 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.73635784 |
30 | melanin biosynthetic process (GO:0042438) | 3.73321675 |
31 | terpenoid biosynthetic process (GO:0016114) | 3.73127329 |
32 | response to pheromone (GO:0019236) | 3.70803039 |
33 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.58767161 |
34 | kinetochore organization (GO:0051383) | 3.58064912 |
35 | secondary metabolite biosynthetic process (GO:0044550) | 3.57717540 |
36 | T-helper 1 type immune response (GO:0042088) | 3.57012334 |
37 | adenosine metabolic process (GO:0046085) | 3.54074376 |
38 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.50830280 |
39 | positive regulation of osteoblast proliferation (GO:0033690) | 3.46179001 |
40 | retinal metabolic process (GO:0042574) | 3.44671164 |
41 | melanin metabolic process (GO:0006582) | 3.40531430 |
42 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.36746351 |
43 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.36556372 |
44 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.35420499 |
45 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.34072538 |
46 | regulation of DNA endoreduplication (GO:0032875) | 3.30057217 |
47 | kinetochore assembly (GO:0051382) | 3.26667136 |
48 | platelet dense granule organization (GO:0060155) | 3.25421424 |
49 | regulation of fever generation (GO:0031620) | 3.25198024 |
50 | protein-lipid complex assembly (GO:0065005) | 3.22823604 |
51 | eye photoreceptor cell development (GO:0042462) | 3.22580281 |
52 | negative regulation of mast cell activation (GO:0033004) | 3.22270529 |
53 | signal peptide processing (GO:0006465) | 3.21731486 |
54 | photoreceptor cell development (GO:0042461) | 3.21641096 |
55 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.20889762 |
56 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.20889762 |
57 | DNA double-strand break processing (GO:0000729) | 3.17347214 |
58 | DNA integration (GO:0015074) | 3.15940780 |
59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.15784973 |
60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.15784973 |
61 | modulation by symbiont of host immune response (GO:0052553) | 3.15784973 |
62 | positive regulation by symbiont of host defense response (GO:0052509) | 3.15784973 |
63 | modulation by symbiont of host defense response (GO:0052031) | 3.15784973 |
64 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.15784973 |
65 | protein-lipid complex remodeling (GO:0034368) | 3.15505787 |
66 | macromolecular complex remodeling (GO:0034367) | 3.15505787 |
67 | plasma lipoprotein particle remodeling (GO:0034369) | 3.15505787 |
68 | cell wall macromolecule catabolic process (GO:0016998) | 3.14776741 |
69 | neutrophil activation (GO:0042119) | 3.14487790 |
70 | positive regulation of action potential (GO:0045760) | 3.13612455 |
71 | negative regulation of sterol transport (GO:0032372) | 3.12300550 |
72 | negative regulation of cholesterol transport (GO:0032375) | 3.12300550 |
73 | positive regulation of response to oxidative stress (GO:1902884) | 3.10893052 |
74 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.10893052 |
75 | protein K11-linked deubiquitination (GO:0035871) | 3.10851196 |
76 | modulation by symbiont of host cellular process (GO:0044068) | 3.09708908 |
77 | IMP biosynthetic process (GO:0006188) | 3.08755065 |
78 | negative regulation of phagocytosis (GO:0050765) | 3.04982836 |
79 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.04399867 |
80 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.04362256 |
81 | regulation of penile erection (GO:0060405) | 3.02234504 |
82 | viral entry into host cell (GO:0046718) | 3.01436971 |
83 | regulation of protein glycosylation (GO:0060049) | 2.98534230 |
84 | ketone body metabolic process (GO:1902224) | 2.97806414 |
85 | replicative senescence (GO:0090399) | 2.97588365 |
86 | mitochondrion distribution (GO:0048311) | 2.96900225 |
87 | behavioral response to ethanol (GO:0048149) | 2.94614593 |
88 | positive regulation of protein homodimerization activity (GO:0090073) | 2.93950275 |
89 | retinal cone cell development (GO:0046549) | 2.93646249 |
90 | regulation of apoptotic cell clearance (GO:2000425) | 2.91903602 |
91 | regulation of immunoglobulin secretion (GO:0051023) | 2.91608971 |
92 | granulocyte activation (GO:0036230) | 2.91396238 |
93 | CENP-A containing nucleosome assembly (GO:0034080) | 2.88421585 |
94 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.83955263 |
95 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.83955263 |
96 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.83955263 |
97 | IMP metabolic process (GO:0046040) | 2.82035428 |
98 | positive regulation of heat generation (GO:0031652) | 2.81230735 |
99 | thrombin receptor signaling pathway (GO:0070493) | 2.81226723 |
100 | regulation of NIK/NF-kappaB signaling (GO:1901222) | 2.80922831 |
101 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.77461500 |
102 | negative regulation of exocytosis (GO:0045920) | 2.77376835 |
103 | nerve growth factor signaling pathway (GO:0038180) | 2.76854007 |
104 | melanosome organization (GO:0032438) | 2.76252741 |
105 | phagocytosis, recognition (GO:0006910) | 2.75086504 |
106 | urinary tract smooth muscle contraction (GO:0014848) | 2.74534856 |
107 | protein localization to kinetochore (GO:0034501) | 2.72881987 |
108 | regulation of cholesterol esterification (GO:0010872) | 2.68548511 |
109 | positive regulation of vasculogenesis (GO:2001214) | 2.67131804 |
110 | atrial cardiac muscle cell action potential (GO:0086014) | 2.65633779 |
111 | phototransduction, visible light (GO:0007603) | 2.65307687 |
112 | growth hormone secretion (GO:0030252) | 2.63597563 |
113 | DNA damage response, detection of DNA damage (GO:0042769) | 2.63317319 |
114 | ovulation from ovarian follicle (GO:0001542) | 2.63268372 |
115 | pigment granule organization (GO:0048753) | 2.62779377 |
116 | acrosome assembly (GO:0001675) | 2.61699839 |
117 | interkinetic nuclear migration (GO:0022027) | 2.61584386 |
118 | regulation of sarcomere organization (GO:0060297) | 2.59691951 |
119 | glial cell proliferation (GO:0014009) | 2.59004884 |
120 | C4-dicarboxylate transport (GO:0015740) | 2.58738722 |
121 | glucose 6-phosphate metabolic process (GO:0051156) | 2.58727650 |
122 | inositol metabolic process (GO:0006020) | 2.57551035 |
123 | detection of light stimulus involved in visual perception (GO:0050908) | 2.55776100 |
124 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.55776100 |
125 | regulation of digestive system process (GO:0044058) | 2.55515114 |
126 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.55419522 |
127 | negative regulation of JUN kinase activity (GO:0043508) | 2.54669677 |
128 | peristalsis (GO:0030432) | 2.54593739 |
129 | dendritic cell migration (GO:0036336) | 2.54191198 |
130 | detection of visible light (GO:0009584) | 2.54046579 |
131 | detection of molecule of bacterial origin (GO:0032490) | 2.52896203 |
132 | regulation of centriole replication (GO:0046599) | 2.52789753 |
133 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.52561936 |
134 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.52320615 |
135 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.51867037 |
136 | quinone biosynthetic process (GO:1901663) | 2.51655974 |
137 | ubiquinone biosynthetic process (GO:0006744) | 2.51655974 |
138 | mitochondrial genome maintenance (GO:0000002) | 2.51078823 |
139 | chromatin remodeling at centromere (GO:0031055) | 2.51064872 |
140 | microtubule anchoring (GO:0034453) | 2.50167224 |
141 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.50103094 |
142 | sulfation (GO:0051923) | 2.49603461 |
143 | retinol metabolic process (GO:0042572) | 2.48878159 |
144 | positive regulation of growth hormone secretion (GO:0060124) | 2.48837339 |
145 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.48431656 |
146 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.47055318 |
147 | short-term memory (GO:0007614) | 2.46806061 |
148 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.46349237 |
149 | cell wall macromolecule metabolic process (GO:0044036) | 2.45594378 |
150 | ubiquinone metabolic process (GO:0006743) | 2.43531696 |
151 | anterograde synaptic vesicle transport (GO:0048490) | 2.43243533 |
152 | presynaptic membrane assembly (GO:0097105) | 2.42317353 |
153 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.41592057 |
154 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.41575804 |
155 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.40701482 |
156 | purine nucleobase metabolic process (GO:0006144) | 2.39970136 |
157 | phototransduction (GO:0007602) | 2.39180001 |
158 | megakaryocyte development (GO:0035855) | 2.38777305 |
159 | detection of light stimulus (GO:0009583) | 2.37852560 |
160 | negative regulation of DNA recombination (GO:0045910) | 2.37180051 |
161 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.36434470 |
162 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.35853113 |
163 | histone H3-K9 methylation (GO:0051567) | 2.35214829 |
164 | mitotic metaphase plate congression (GO:0007080) | 2.34878713 |
165 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.33508895 |
166 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.33508895 |
167 | visual perception (GO:0007601) | 2.32988315 |
168 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.32822556 |
169 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.32822556 |
170 | protein-cofactor linkage (GO:0018065) | 2.32510686 |
171 | sensory perception of light stimulus (GO:0050953) | 2.31370540 |
172 | pericardium development (GO:0060039) | 2.31068025 |
173 | behavioral response to nicotine (GO:0035095) | 2.30848089 |
174 | Rap protein signal transduction (GO:0032486) | 2.30640033 |
175 | N-acetylglucosamine metabolic process (GO:0006044) | 2.29615160 |
176 | negative regulation of dendrite development (GO:2000171) | 2.29409613 |
177 | meiotic chromosome segregation (GO:0045132) | 2.29320846 |
178 | response to hyperoxia (GO:0055093) | 2.29317023 |
179 | response to increased oxygen levels (GO:0036296) | 2.29317023 |
180 | retinoid metabolic process (GO:0001523) | 2.29150361 |
181 | heart process (GO:0003015) | 2.28937999 |
182 | heart contraction (GO:0060047) | 2.28937999 |
183 | nucleotide transmembrane transport (GO:1901679) | 2.28906583 |
184 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.28762156 |
185 | sister chromatid segregation (GO:0000819) | 2.28645717 |
186 | maturation of 5.8S rRNA (GO:0000460) | 2.27491299 |
187 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.27381137 |
188 | ether lipid metabolic process (GO:0046485) | 2.25358083 |
189 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.24539424 |
190 | response to host immune response (GO:0052572) | 2.23221701 |
191 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.23221701 |
192 | regulation of heat generation (GO:0031650) | 2.22910713 |
193 | negative regulation of neurotransmitter transport (GO:0051589) | 2.22333929 |
194 | COPI coating of Golgi vesicle (GO:0048205) | 2.21069236 |
195 | Golgi transport vesicle coating (GO:0048200) | 2.21069236 |
196 | establishment of chromosome localization (GO:0051303) | 2.20963106 |
197 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.20474973 |
198 | viral mRNA export from host cell nucleus (GO:0046784) | 2.20342757 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.61492718 |
2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.35318103 |
3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.85489517 |
4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.20125697 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.99409032 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.94917640 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.91295789 |
8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.81755047 |
9 | FUS_26573619_Chip-Seq_HEK293_Human | 2.77584746 |
10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.73891560 |
11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.64490804 |
12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.64387715 |
13 | EWS_26573619_Chip-Seq_HEK293_Human | 2.42805796 |
14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.30389623 |
15 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.26738705 |
16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.25268077 |
17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.21732365 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18394861 |
19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.18084583 |
20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.08633960 |
21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.00059322 |
22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.98804040 |
23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.96451514 |
24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.95372298 |
25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.93740793 |
26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.91146793 |
27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89469908 |
28 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88445592 |
29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86672370 |
30 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.86615769 |
31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86503802 |
32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.85771716 |
33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.85087061 |
34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.77157146 |
35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.73108463 |
36 | STAT3_23295773_ChIP-Seq_U87_Human | 1.72494910 |
37 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.71282811 |
38 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.71282811 |
39 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.71010107 |
40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70446803 |
41 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.67706742 |
42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65414276 |
43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.61833608 |
44 | TCF4_23295773_ChIP-Seq_U87_Human | 1.59388749 |
45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.56351403 |
46 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.55638832 |
47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55638832 |
48 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.55548750 |
49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54740029 |
50 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.54279839 |
51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.52233999 |
52 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.50828719 |
53 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49643478 |
54 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.49141583 |
55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.48715331 |
56 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.48686837 |
57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.47597288 |
58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46222533 |
59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45093787 |
60 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44991860 |
61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.44286992 |
62 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.43834335 |
63 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.41830631 |
64 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.40353301 |
65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.40105201 |
66 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.37276779 |
67 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.36615889 |
68 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.36342026 |
69 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36137173 |
70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35057271 |
71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34759937 |
72 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.30795710 |
73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30578995 |
74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30578995 |
75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.30398966 |
76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.30286574 |
77 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30001822 |
78 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.29677487 |
79 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.29347088 |
80 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.29221081 |
81 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.28187279 |
82 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.26359351 |
83 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26306204 |
84 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.25922495 |
85 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25315055 |
86 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24845410 |
87 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24720150 |
88 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.24564242 |
89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.22923310 |
90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21915495 |
91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21815039 |
92 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.21771533 |
93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20991078 |
94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20392804 |
95 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20197003 |
96 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.20138503 |
97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.19582056 |
98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19374080 |
99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.18663627 |
100 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18334697 |
101 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18316169 |
102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18257442 |
103 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17429456 |
104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16765074 |
105 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.16578403 |
106 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.15173837 |
107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14564676 |
108 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.14520079 |
109 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12076988 |
110 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10953604 |
111 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.10716985 |
112 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10315300 |
113 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.10106607 |
114 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09388701 |
115 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08931844 |
116 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08532641 |
117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07656019 |
118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06272841 |
119 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.05684548 |
120 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.05549268 |
121 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04831129 |
122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04712836 |
123 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03748499 |
124 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03408665 |
125 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.03163487 |
126 | JUN_21703547_ChIP-Seq_K562_Human | 1.03057137 |
127 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02876721 |
128 | TBL1_22424771_ChIP-Seq_293T_Human | 1.02488026 |
129 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.02407708 |
130 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02123733 |
131 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.01829520 |
132 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.01741964 |
133 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01602636 |
134 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.00437188 |
135 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.00269404 |
136 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97767831 |
137 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97733888 |
138 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.97646665 |
139 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97396781 |
140 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.96702817 |
141 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.96327567 |
142 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96296754 |
143 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.96117030 |
144 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96054174 |
145 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95839822 |
146 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95595362 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005248_abnormal_Harderian_gland | 5.37481397 |
2 | MP0003011_delayed_dark_adaptation | 4.90457627 |
3 | MP0005646_abnormal_pituitary_gland | 3.56372793 |
4 | MP0009697_abnormal_copulation | 3.55021145 |
5 | MP0005377_hearing/vestibular/ear_phenot | 3.47307763 |
6 | MP0003878_abnormal_ear_physiology | 3.47307763 |
7 | MP0004147_increased_porphyrin_level | 3.42324009 |
8 | MP0009840_abnormal_foam_cell | 3.35481295 |
9 | MP0001188_hyperpigmentation | 3.33015027 |
10 | MP0000569_abnormal_digit_pigmentation | 3.22539071 |
11 | MP0006072_abnormal_retinal_apoptosis | 2.97215801 |
12 | MP0000372_irregular_coat_pigmentation | 2.90506846 |
13 | MP0005253_abnormal_eye_physiology | 2.85944780 |
14 | MP0003123_paternal_imprinting | 2.84977064 |
15 | MP0003880_abnormal_central_pattern | 2.83654011 |
16 | MP0009780_abnormal_chondrocyte_physiolo | 2.72285808 |
17 | MP0001835_abnormal_antigen_presentation | 2.64072944 |
18 | MP0005257_abnormal_intraocular_pressure | 2.51677454 |
19 | MP0002396_abnormal_hematopoietic_system | 2.49007140 |
20 | MP0005408_hypopigmentation | 2.40970428 |
21 | MP0004782_abnormal_surfactant_physiolog | 2.31462745 |
22 | MP0005171_absent_coat_pigmentation | 2.21695834 |
23 | MP0010094_abnormal_chromosome_stability | 2.15782216 |
24 | MP0001986_abnormal_taste_sensitivity | 2.07722465 |
25 | MP0008057_abnormal_DNA_replication | 2.07055749 |
26 | MP0006276_abnormal_autonomic_nervous | 2.02312758 |
27 | MP0002876_abnormal_thyroid_physiology | 2.01460337 |
28 | MP0005551_abnormal_eye_electrophysiolog | 2.01125864 |
29 | MP0004270_analgesia | 1.93746681 |
30 | MP0006292_abnormal_olfactory_placode | 1.90913919 |
31 | MP0002127_abnormal_cardiovascular_syste | 1.88289958 |
32 | MP0001324_abnormal_eye_pigmentation | 1.87012685 |
33 | MP0002419_abnormal_innate_immunity | 1.84986582 |
34 | MP0009785_altered_susceptibility_to | 1.81830754 |
35 | MP0002102_abnormal_ear_morphology | 1.77271752 |
36 | MP0001879_abnormal_lymphatic_vessel | 1.73367683 |
37 | MP0006054_spinal_hemorrhage | 1.72408530 |
38 | MP0002148_abnormal_hypersensitivity_rea | 1.70588080 |
39 | MP0008058_abnormal_DNA_repair | 1.67654716 |
40 | MP0001293_anophthalmia | 1.66154557 |
41 | MP0005360_urolithiasis | 1.65619782 |
42 | MP0003121_genomic_imprinting | 1.63013656 |
43 | MP0001984_abnormal_olfaction | 1.61396549 |
44 | MP0005379_endocrine/exocrine_gland_phen | 1.61050701 |
45 | MP0005423_abnormal_somatic_nervous | 1.61029886 |
46 | MP0005391_vision/eye_phenotype | 1.59919609 |
47 | MP0003136_yellow_coat_color | 1.54271631 |
48 | MP0002332_abnormal_exercise_endurance | 1.52660658 |
49 | MP0001529_abnormal_vocalization | 1.49725122 |
50 | MP0000371_diluted_coat_color | 1.47760196 |
51 | MP0005174_abnormal_tail_pigmentation | 1.47736359 |
52 | MP0005195_abnormal_posterior_eye | 1.47227505 |
53 | MP0002938_white_spotting | 1.44533534 |
54 | MP0000427_abnormal_hair_cycle | 1.43472392 |
55 | MP0004859_abnormal_synaptic_plasticity | 1.40916524 |
56 | MP0005000_abnormal_immune_tolerance | 1.38235284 |
57 | MP0008007_abnormal_cellular_replicative | 1.36851271 |
58 | MP0009046_muscle_twitch | 1.36837540 |
59 | MP0003787_abnormal_imprinting | 1.36621888 |
60 | MP0009745_abnormal_behavioral_response | 1.35202224 |
61 | MP0009764_decreased_sensitivity_to | 1.31428315 |
62 | MP0004084_abnormal_cardiac_muscle | 1.31025654 |
63 | MP0002452_abnormal_antigen_presenting | 1.30430937 |
64 | MP0010030_abnormal_orbit_morphology | 1.29524394 |
65 | MP0000465_gastrointestinal_hemorrhage | 1.29404853 |
66 | MP0008877_abnormal_DNA_methylation | 1.27442896 |
67 | MP0002064_seizures | 1.26582761 |
68 | MP0001348_abnormal_lacrimal_gland | 1.25023613 |
69 | MP0003122_maternal_imprinting | 1.24188231 |
70 | MP0010352_gastrointestinal_tract_polyps | 1.23969144 |
71 | MP0002075_abnormal_coat/hair_pigmentati | 1.23470193 |
72 | MP0003890_abnormal_embryonic-extraembry | 1.23377330 |
73 | MP0003436_decreased_susceptibility_to | 1.21046618 |
74 | MP0003656_abnormal_erythrocyte_physiolo | 1.20311874 |
75 | MP0000778_abnormal_nervous_system | 1.19961008 |
76 | MP0004808_abnormal_hematopoietic_stem | 1.17637825 |
77 | MP0003186_abnormal_redox_activity | 1.15619561 |
78 | MP0000015_abnormal_ear_pigmentation | 1.14885286 |
79 | MP0003111_abnormal_nucleus_morphology | 1.14366599 |
80 | MP0001905_abnormal_dopamine_level | 1.12173490 |
81 | MP0002420_abnormal_adaptive_immunity | 1.12111099 |
82 | MP0001819_abnormal_immune_cell | 1.09858133 |
83 | MP0002163_abnormal_gland_morphology | 1.09476571 |
84 | MP0004233_abnormal_muscle_weight | 1.09158758 |
85 | MP0001800_abnormal_humoral_immune | 1.08912674 |
86 | MP0008789_abnormal_olfactory_epithelium | 1.08853173 |
87 | MP0008775_abnormal_heart_ventricle | 1.08551945 |
88 | MP0002751_abnormal_autonomic_nervous | 1.08136485 |
89 | MP0000631_abnormal_neuroendocrine_gland | 1.08085869 |
90 | MP0005503_abnormal_tendon_morphology | 1.07996430 |
91 | MP0003943_abnormal_hepatobiliary_system | 1.07486204 |
92 | MP0003077_abnormal_cell_cycle | 1.07268324 |
93 | MP0010307_abnormal_tumor_latency | 1.06690845 |
94 | MP0002095_abnormal_skin_pigmentation | 1.06523826 |
95 | MP0002928_abnormal_bile_duct | 1.06271326 |
96 | MP0002723_abnormal_immune_serum | 1.04150659 |
97 | MP0003950_abnormal_plasma_membrane | 1.03957387 |
98 | MP0002734_abnormal_mechanical_nocicepti | 1.03499673 |
99 | MP0004924_abnormal_behavior | 1.03170755 |
100 | MP0005386_behavior/neurological_phenoty | 1.03170755 |
101 | MP0003724_increased_susceptibility_to | 1.03006387 |
102 | MP0004134_abnormal_chest_morphology | 1.02033953 |
103 | MP0005671_abnormal_response_to | 1.01577764 |
104 | MP0003300_gastrointestinal_ulcer | 1.01129170 |
105 | MP0003718_maternal_effect | 1.00824734 |
106 | MP0002006_tumorigenesis | 1.00804673 |
107 | MP0000566_synostosis | 1.00391465 |
108 | MP0003385_abnormal_body_wall | 1.00105969 |
109 | MP0005394_taste/olfaction_phenotype | 0.97590699 |
110 | MP0005499_abnormal_olfactory_system | 0.97590699 |
111 | MP0004142_abnormal_muscle_tone | 0.97577999 |
112 | MP0005387_immune_system_phenotype | 0.97087388 |
113 | MP0001790_abnormal_immune_system | 0.97087388 |
114 | MP0001485_abnormal_pinna_reflex | 0.96374099 |
115 | MP0005197_abnormal_uvea_morphology | 0.96033760 |
116 | MP0002090_abnormal_vision | 0.95692862 |
117 | MP0002736_abnormal_nociception_after | 0.95652016 |
118 | MP0000343_altered_response_to | 0.95113712 |
119 | MP0001968_abnormal_touch/_nociception | 0.94452693 |
120 | MP0000516_abnormal_urinary_system | 0.94111122 |
121 | MP0005367_renal/urinary_system_phenotyp | 0.94111122 |
122 | MP0001764_abnormal_homeostasis | 0.94062620 |
123 | MP0001177_atelectasis | 0.93408005 |
124 | MP0002272_abnormal_nervous_system | 0.93179450 |
125 | MP0002735_abnormal_chemical_nociception | 0.90806784 |
126 | MP0001501_abnormal_sleep_pattern | 0.90306996 |
127 | MP0002184_abnormal_innervation | 0.90107816 |
128 | MP0005220_abnormal_exocrine_pancreas | 0.89511410 |
129 | MP0004510_myositis | 0.88698576 |
130 | MP0002638_abnormal_pupillary_reflex | 0.88156855 |
131 | MP0003566_abnormal_cell_adhesion | 0.87685929 |
132 | MP0004264_abnormal_extraembryonic_tissu | 0.87153328 |
133 | MP0001186_pigmentation_phenotype | 0.86785502 |
134 | MP0005397_hematopoietic_system_phenotyp | 0.85219401 |
135 | MP0001545_abnormal_hematopoietic_system | 0.85219401 |
136 | MP0001440_abnormal_grooming_behavior | 0.85178127 |
137 | MP0004272_abnormal_basement_membrane | 0.84348819 |
138 | MP0002398_abnormal_bone_marrow | 0.84021671 |
139 | MP0001963_abnormal_hearing_physiology | 0.83913464 |
140 | MP0001119_abnormal_female_reproductive | 0.82783998 |
141 | MP0005164_abnormal_response_to | 0.82783000 |
142 | MP0002089_abnormal_postnatal_growth/wei | 0.81062658 |
143 | MP0002752_abnormal_somatic_nervous | 0.81053231 |
144 | MP0005376_homeostasis/metabolism_phenot | 0.80820126 |
145 | MP0001486_abnormal_startle_reflex | 0.80370933 |
146 | MP0002063_abnormal_learning/memory/cond | 0.80278387 |
147 | MP0004215_abnormal_myocardial_fiber | 0.77807585 |
148 | MP0005390_skeleton_phenotype | 0.77396724 |
149 | MP0005409_darkened_coat_color | 0.76816646 |
150 | MP0003635_abnormal_synaptic_transmissio | 0.76574774 |
151 | MP0005025_abnormal_response_to | 0.76480354 |
152 | MP0000716_abnormal_immune_system | 0.73795419 |
153 | MP0002697_abnormal_eye_size | 0.73176791 |
154 | MP0001533_abnormal_skeleton_physiology | 0.73036464 |
155 | MP0003690_abnormal_glial_cell | 0.72914995 |
156 | MP0005084_abnormal_gallbladder_morpholo | 0.71817832 |
157 | MP0002998_abnormal_bone_remodeling | 0.71425338 |
158 | MP0002160_abnormal_reproductive_system | 0.70877875 |
159 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70689461 |
160 | MP0005076_abnormal_cell_differentiation | 0.70352401 |
161 | MP0001286_abnormal_eye_development | 0.70017226 |
162 | MP0001845_abnormal_inflammatory_respons | 0.70005849 |
163 | MP0000639_abnormal_adrenal_gland | 0.69230581 |
164 | MP0005389_reproductive_system_phenotype | 0.64662054 |
165 | MP0002233_abnormal_nose_morphology | 0.64103033 |
166 | MP0003755_abnormal_palate_morphology | 0.63738477 |
167 | MP0002882_abnormal_neuron_morphology | 0.63692720 |
168 | MP0003195_calcinosis | 0.63415014 |
169 | MP0005187_abnormal_penis_morphology | 0.62338266 |
170 | MP0001299_abnormal_eye_distance/ | 0.62332479 |
171 | MP0008961_abnormal_basal_metabolism | 0.62146078 |
172 | MP0010386_abnormal_urinary_bladder | 0.60577497 |
173 | MP0002229_neurodegeneration | 0.60339807 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Choroideremia (HP:0001139) | 6.31789611 |
2 | Abnormality of the fovea (HP:0000493) | 5.56461629 |
3 | Dyschromatopsia (HP:0007641) | 4.52368499 |
4 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.42422277 |
5 | Hypopigmentation of the fundus (HP:0007894) | 4.25768556 |
6 | Submucous cleft hard palate (HP:0000176) | 4.24249951 |
7 | Irregular epiphyses (HP:0010582) | 4.10991047 |
8 | Macular degeneration (HP:0000608) | 3.94870847 |
9 | Hypobetalipoproteinemia (HP:0003563) | 3.76942279 |
10 | Small epiphyses (HP:0010585) | 3.61259773 |
11 | Asymmetry of the thorax (HP:0001555) | 3.54728094 |
12 | Hyperventilation (HP:0002883) | 3.44257674 |
13 | Abnormality of the nasal septum (HP:0000419) | 3.38637255 |
14 | Abnormality of the astrocytes (HP:0100707) | 3.38331022 |
15 | Astrocytoma (HP:0009592) | 3.38331022 |
16 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.34902090 |
17 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.25871341 |
18 | Abnormal hair whorl (HP:0010721) | 3.25485845 |
19 | Fair hair (HP:0002286) | 3.25165415 |
20 | Papillary thyroid carcinoma (HP:0002895) | 3.24603529 |
21 | Neoplasm of the adrenal cortex (HP:0100641) | 3.21246114 |
22 | Flat capital femoral epiphysis (HP:0003370) | 3.17387347 |
23 | Pigmentary retinal degeneration (HP:0001146) | 3.16282646 |
24 | Cellulitis (HP:0100658) | 3.11322080 |
25 | Scotoma (HP:0000575) | 3.03794137 |
26 | Cutaneous melanoma (HP:0012056) | 3.01723088 |
27 | Chronic hepatic failure (HP:0100626) | 2.99685128 |
28 | Hepatoblastoma (HP:0002884) | 2.99332328 |
29 | Epiphyseal dysplasia (HP:0002656) | 2.97875599 |
30 | Pendular nystagmus (HP:0012043) | 2.95047114 |
31 | Abnormal foot bone ossification (HP:0010675) | 2.89226655 |
32 | Spinal cord lesions (HP:0100561) | 2.87724626 |
33 | Syringomyelia (HP:0003396) | 2.87724626 |
34 | Cerebellar dysplasia (HP:0007033) | 2.83600704 |
35 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.81271771 |
36 | Absent epiphyses (HP:0010577) | 2.81271771 |
37 | Scanning speech (HP:0002168) | 2.78598736 |
38 | Microglossia (HP:0000171) | 2.75756330 |
39 | Prostate neoplasm (HP:0100787) | 2.74153747 |
40 | Genital tract atresia (HP:0001827) | 2.73343680 |
41 | Generalized hypopigmentation of hair (HP:0011358) | 2.72473281 |
42 | Type 2 muscle fiber atrophy (HP:0003554) | 2.71332665 |
43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71194182 |
44 | Tubulointerstitial nephritis (HP:0001970) | 2.70199445 |
45 | Abnormality of macular pigmentation (HP:0008002) | 2.69781739 |
46 | Abolished electroretinogram (ERG) (HP:0000550) | 2.69722483 |
47 | Congenital primary aphakia (HP:0007707) | 2.69214893 |
48 | Abnormality of placental membranes (HP:0011409) | 2.68694312 |
49 | Amniotic constriction ring (HP:0009775) | 2.68694312 |
50 | Medial flaring of the eyebrow (HP:0010747) | 2.68539456 |
51 | Gait imbalance (HP:0002141) | 2.68237876 |
52 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.66110087 |
53 | Pancreatic fibrosis (HP:0100732) | 2.65650560 |
54 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.65311108 |
55 | Severe Myopia (HP:0011003) | 2.62263586 |
56 | Pancreatic cysts (HP:0001737) | 2.60528315 |
57 | Optic nerve hypoplasia (HP:0000609) | 2.59488161 |
58 | Hypoplasia of the fovea (HP:0007750) | 2.57991316 |
59 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.57991316 |
60 | Fetal akinesia sequence (HP:0001989) | 2.57749078 |
61 | Ependymoma (HP:0002888) | 2.56844163 |
62 | Glioma (HP:0009733) | 2.55982921 |
63 | Progressive cerebellar ataxia (HP:0002073) | 2.55939682 |
64 | Calf muscle hypertrophy (HP:0008981) | 2.54662713 |
65 | Autoamputation (HP:0001218) | 2.53038863 |
66 | Popliteal pterygium (HP:0009756) | 2.49160658 |
67 | Protruding tongue (HP:0010808) | 2.47692763 |
68 | Hypokinesia (HP:0002375) | 2.45622392 |
69 | Abnormality of incisor morphology (HP:0011063) | 2.44558380 |
70 | Rough bone trabeculation (HP:0100670) | 2.43440994 |
71 | Short chin (HP:0000331) | 2.42369829 |
72 | Vaginal atresia (HP:0000148) | 2.42133062 |
73 | Type II lissencephaly (HP:0007260) | 2.41653047 |
74 | Nephrogenic diabetes insipidus (HP:0009806) | 2.41548334 |
75 | Abnormal tarsal ossification (HP:0008369) | 2.39680478 |
76 | Poor coordination (HP:0002370) | 2.37185043 |
77 | Irregular vertebral endplates (HP:0003301) | 2.36734245 |
78 | Thyroid carcinoma (HP:0002890) | 2.36426109 |
79 | Barrel-shaped chest (HP:0001552) | 2.34650271 |
80 | Embryonal renal neoplasm (HP:0011794) | 2.31482764 |
81 | Febrile seizures (HP:0002373) | 2.28219881 |
82 | Relative macrocephaly (HP:0004482) | 2.27697804 |
83 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.27652919 |
84 | Mesomelia (HP:0003027) | 2.27439382 |
85 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.25615580 |
86 | Molar tooth sign on MRI (HP:0002419) | 2.25612891 |
87 | Abnormality of midbrain morphology (HP:0002418) | 2.25612891 |
88 | Hyperlipoproteinemia (HP:0010980) | 2.24063538 |
89 | Renal Fanconi syndrome (HP:0001994) | 2.24002370 |
90 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.23041354 |
91 | Retinal dysplasia (HP:0007973) | 2.21359850 |
92 | Muscle fiber atrophy (HP:0100295) | 2.20001231 |
93 | Genetic anticipation (HP:0003743) | 2.18052136 |
94 | Colon cancer (HP:0003003) | 2.16194384 |
95 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.15417636 |
96 | Chromsome breakage (HP:0040012) | 2.14589053 |
97 | Atonic seizures (HP:0010819) | 2.14561995 |
98 | Bone marrow hypocellularity (HP:0005528) | 2.13591983 |
99 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.13263518 |
100 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.11404664 |
101 | Neoplasm of the adrenal gland (HP:0100631) | 2.11028087 |
102 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.10537764 |
103 | Birth length less than 3rd percentile (HP:0003561) | 2.10411789 |
104 | Shoulder girdle muscle weakness (HP:0003547) | 2.09970231 |
105 | Abnormality of the vertebral endplates (HP:0005106) | 2.09829634 |
106 | Abnormality of the labia minora (HP:0012880) | 2.09653018 |
107 | Blue irides (HP:0000635) | 2.09259344 |
108 | Vitreoretinal degeneration (HP:0000655) | 2.09005398 |
109 | Lissencephaly (HP:0001339) | 2.08492762 |
110 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.07858304 |
111 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.07858304 |
112 | Clubbing of toes (HP:0100760) | 2.07608317 |
113 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.07333497 |
114 | Bifid tongue (HP:0010297) | 2.07083747 |
115 | Recurrent lower respiratory tract infections (HP:0002783) | 2.06222403 |
116 | Hypochromic anemia (HP:0001931) | 2.05684569 |
117 | Deep philtrum (HP:0002002) | 2.05512987 |
118 | Recurrent abscess formation (HP:0002722) | 2.04304466 |
119 | Keratoconjunctivitis sicca (HP:0001097) | 2.04234805 |
120 | Supernumerary spleens (HP:0009799) | 2.04171121 |
121 | Epileptic encephalopathy (HP:0200134) | 2.04131224 |
122 | Proximal amyotrophy (HP:0007126) | 2.03774805 |
123 | Thyroiditis (HP:0100646) | 2.03661362 |
124 | Attenuation of retinal blood vessels (HP:0007843) | 2.02720076 |
125 | Abnormality of the femoral head (HP:0003368) | 2.02149974 |
126 | Recurrent pneumonia (HP:0006532) | 2.01832994 |
127 | Drooling (HP:0002307) | 2.01496569 |
128 | Melanoma (HP:0002861) | 2.01222504 |
129 | Abnormal trabecular bone morphology (HP:0100671) | 2.00474296 |
130 | Neutropenia (HP:0001875) | 1.99702039 |
131 | Focal motor seizures (HP:0011153) | 1.99231754 |
132 | Horizontal nystagmus (HP:0000666) | 1.99006765 |
133 | Increased IgM level (HP:0003496) | 1.98960803 |
134 | Premature graying of hair (HP:0002216) | 1.98711796 |
135 | Chorioretinal atrophy (HP:0000533) | 1.98307515 |
136 | Encephalitis (HP:0002383) | 1.98113657 |
137 | Abnormality of the prostate (HP:0008775) | 1.97883012 |
138 | Freckling (HP:0001480) | 1.96851965 |
139 | Pelvic girdle muscle weakness (HP:0003749) | 1.96026052 |
140 | Abnormal biliary tract physiology (HP:0012439) | 1.94736264 |
141 | Bile duct proliferation (HP:0001408) | 1.94736264 |
142 | Stomatitis (HP:0010280) | 1.94717436 |
143 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.93518543 |
144 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.91613101 |
145 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.91613101 |
146 | Abnormality of the metopic suture (HP:0005556) | 1.91254956 |
147 | Stillbirth (HP:0003826) | 1.91002444 |
148 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.90428438 |
149 | Severe visual impairment (HP:0001141) | 1.90300312 |
150 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.90125354 |
151 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.89812951 |
152 | Abnormality of femoral epiphyses (HP:0006499) | 1.89812951 |
153 | Clumsiness (HP:0002312) | 1.89327878 |
154 | Hyperglycinemia (HP:0002154) | 1.88469787 |
155 | Abnormality of the preputium (HP:0100587) | 1.88295341 |
156 | Abnormality of binocular vision (HP:0011514) | 1.87237626 |
157 | Diplopia (HP:0000651) | 1.87237626 |
158 | Onycholysis (HP:0001806) | 1.86451070 |
159 | Abnormality of T cell physiology (HP:0011840) | 1.86102444 |
160 | Occipital encephalocele (HP:0002085) | 1.85853588 |
161 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.84911814 |
162 | Meckel diverticulum (HP:0002245) | 1.84846290 |
163 | True hermaphroditism (HP:0010459) | 1.83913398 |
164 | Metaphyseal cupping (HP:0003021) | 1.83196661 |
165 | Heterotopia (HP:0002282) | 1.83018309 |
166 | Adrenal hypoplasia (HP:0000835) | 1.82669866 |
167 | Gaze-evoked nystagmus (HP:0000640) | 1.82610745 |
168 | Glycosuria (HP:0003076) | 1.82526080 |
169 | Abnormality of urine glucose concentration (HP:0011016) | 1.82526080 |
170 | Abnormality of T cell number (HP:0011839) | 1.82169793 |
171 | Microcytic anemia (HP:0001935) | 1.82153931 |
172 | 11 pairs of ribs (HP:0000878) | 1.81990444 |
173 | Distal lower limb muscle weakness (HP:0009053) | 1.81906036 |
174 | Short tibia (HP:0005736) | 1.81594870 |
175 | Nephronophthisis (HP:0000090) | 1.81237365 |
176 | Absent frontal sinuses (HP:0002688) | 1.80629267 |
177 | Acute necrotizing encephalopathy (HP:0006965) | 1.80437050 |
178 | Generalized hypopigmentation (HP:0007513) | 1.78762100 |
179 | Abnormality of the ileum (HP:0001549) | 1.78621037 |
180 | Cystic hygroma (HP:0000476) | 1.78161335 |
181 | Facial hemangioma (HP:0000329) | 1.78016615 |
182 | Absent speech (HP:0001344) | 1.77619384 |
183 | Albinism (HP:0001022) | 1.77355546 |
184 | Lower limb asymmetry (HP:0100559) | 1.77097467 |
185 | Fibular hypoplasia (HP:0003038) | 1.76733877 |
186 | Abnormality of the anterior horn cell (HP:0006802) | 1.76692300 |
187 | Degeneration of anterior horn cells (HP:0002398) | 1.76692300 |
188 | Abnormality of the neuromuscular junction (HP:0003398) | 1.76428900 |
189 | Fatigable weakness (HP:0003473) | 1.76428900 |
190 | Abnormality of T cells (HP:0002843) | 1.76150788 |
191 | Alveolar cell carcinoma (HP:0006519) | 1.76126942 |
192 | Flattened epiphyses (HP:0003071) | 1.75972938 |
193 | Keratoconjunctivitis (HP:0001096) | 1.75832977 |
194 | Abnormality of chromosome stability (HP:0003220) | 1.74360006 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIM28 | 5.47781233 |
2 | CDK12 | 4.61276765 |
3 | MST4 | 3.34658595 |
4 | AKT3 | 3.15525028 |
5 | CASK | 2.78193044 |
6 | PLK2 | 2.69985911 |
7 | WNK3 | 2.50285543 |
8 | NUAK1 | 2.49516295 |
9 | TNK2 | 2.41398900 |
10 | EIF2AK3 | 2.37895961 |
11 | MAP3K14 | 2.30339212 |
12 | NME1 | 2.26135788 |
13 | EIF2AK1 | 2.25476641 |
14 | FGFR2 | 2.22312881 |
15 | PBK | 2.11262254 |
16 | IRAK3 | 2.09992031 |
17 | CLK1 | 2.05229398 |
18 | PLK3 | 1.90504368 |
19 | MKNK1 | 1.90430170 |
20 | TNIK | 1.87490845 |
21 | BRD4 | 1.87486901 |
22 | MAP3K4 | 1.82747631 |
23 | BMPR2 | 1.81009285 |
24 | BCR | 1.73612980 |
25 | MARK3 | 1.70995020 |
26 | SGK2 | 1.67823352 |
27 | TESK2 | 1.67098317 |
28 | BCKDK | 1.66540937 |
29 | TXK | 1.61563022 |
30 | TSSK6 | 1.60948719 |
31 | MET | 1.56559576 |
32 | STK38L | 1.56281658 |
33 | EIF2AK2 | 1.53977870 |
34 | SIK3 | 1.43548936 |
35 | MKNK2 | 1.40538208 |
36 | MYLK | 1.38785274 |
37 | DDR2 | 1.35462202 |
38 | BRSK2 | 1.34058210 |
39 | ERBB3 | 1.31813503 |
40 | CSNK1A1L | 1.25673045 |
41 | PLK4 | 1.22526130 |
42 | ZAK | 1.20101447 |
43 | OBSCN | 1.19208978 |
44 | MAP3K12 | 1.18293728 |
45 | SGK3 | 1.17608485 |
46 | DAPK1 | 1.12758503 |
47 | MST1R | 1.12022254 |
48 | CSNK1G2 | 1.11452681 |
49 | MAP2K7 | 1.10774154 |
50 | EPHA4 | 1.10407699 |
51 | NEK6 | 1.06050951 |
52 | ERBB4 | 1.04672847 |
53 | YES1 | 1.03908299 |
54 | CDK19 | 1.03372541 |
55 | FRK | 1.02651527 |
56 | MAP2K3 | 1.01716257 |
57 | CDC7 | 0.98888863 |
58 | NTRK3 | 0.98841746 |
59 | SRPK1 | 0.98067785 |
60 | CSNK1G1 | 0.98048186 |
61 | INSRR | 0.97252623 |
62 | STK10 | 0.91285695 |
63 | STK39 | 0.89240488 |
64 | IRAK4 | 0.88980794 |
65 | PASK | 0.87219541 |
66 | ADRBK1 | 0.86632206 |
67 | MAPK7 | 0.85612691 |
68 | PRKCE | 0.84887331 |
69 | MARK1 | 0.84005827 |
70 | CCNB1 | 0.82397929 |
71 | RAF1 | 0.81661952 |
72 | SGK494 | 0.81170545 |
73 | SGK223 | 0.81170545 |
74 | CSNK1G3 | 0.80542450 |
75 | DYRK1A | 0.78713933 |
76 | OXSR1 | 0.77840744 |
77 | TGFBR1 | 0.77365360 |
78 | STK38 | 0.76759693 |
79 | PRKG2 | 0.76622239 |
80 | LATS1 | 0.73709521 |
81 | PIM1 | 0.73067345 |
82 | BMPR1B | 0.72824830 |
83 | PIK3CA | 0.70897919 |
84 | KSR1 | 0.69984701 |
85 | MINK1 | 0.68707814 |
86 | CDK8 | 0.67122083 |
87 | NEK9 | 0.66570236 |
88 | STK4 | 0.66026554 |
89 | PIK3CG | 0.64718121 |
90 | TEC | 0.64584088 |
91 | RPS6KC1 | 0.64152555 |
92 | RPS6KL1 | 0.64152555 |
93 | FER | 0.63864129 |
94 | BMX | 0.63342202 |
95 | PKN1 | 0.62892403 |
96 | TIE1 | 0.61568596 |
97 | DYRK2 | 0.60619320 |
98 | RIPK4 | 0.60527404 |
99 | LIMK1 | 0.57684096 |
100 | MAP3K3 | 0.57149926 |
101 | RPS6KA6 | 0.55423291 |
102 | CAMK1G | 0.53764851 |
103 | TAOK3 | 0.53293214 |
104 | PAK6 | 0.53087011 |
105 | MUSK | 0.52991637 |
106 | GRK7 | 0.52766320 |
107 | BRAF | 0.52637240 |
108 | CAMK2A | 0.51145341 |
109 | PRKAA2 | 0.48540826 |
110 | FGFR3 | 0.48262890 |
111 | PRKCZ | 0.48124146 |
112 | PLK1 | 0.47000880 |
113 | BTK | 0.46807681 |
114 | PRKACB | 0.45511162 |
115 | CDK9 | 0.44109458 |
116 | ADRBK2 | 0.43468110 |
117 | HIPK2 | 0.42498116 |
118 | PRKCD | 0.42399958 |
119 | NLK | 0.41380202 |
120 | MAPKAPK2 | 0.41233212 |
121 | GRK5 | 0.40835554 |
122 | LYN | 0.40638485 |
123 | PRKCG | 0.40008959 |
124 | CDK5 | 0.38969986 |
125 | MAPK13 | 0.37956996 |
126 | ACVR1B | 0.37417920 |
127 | GRK1 | 0.36957105 |
128 | ATM | 0.36470595 |
129 | MAP3K6 | 0.35943684 |
130 | PDK2 | 0.35841016 |
131 | PAK3 | 0.35734858 |
132 | DYRK3 | 0.35618565 |
133 | CAMK2B | 0.35461609 |
134 | PRKG1 | 0.35447742 |
135 | PRKAA1 | 0.34996286 |
136 | CAMK2G | 0.34416351 |
137 | STK3 | 0.34163037 |
138 | VRK1 | 0.33887546 |
139 | ATR | 0.33756187 |
140 | RPS6KB1 | 0.32952020 |
141 | CAMK1D | 0.32267797 |
142 | PINK1 | 0.31547098 |
143 | ROCK1 | 0.29640492 |
144 | WNK4 | 0.28942236 |
145 | MAP2K4 | 0.27368116 |
146 | MELK | 0.26655956 |
147 | FLT3 | 0.25128990 |
148 | CSNK1D | 0.24356689 |
149 | BUB1 | 0.24026474 |
150 | TAF1 | 0.18952593 |
151 | MAP3K5 | 0.18894064 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.92648047 |
2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.89529240 |
3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.79752052 |
4 | Protein export_Homo sapiens_hsa03060 | 2.54818565 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.52598621 |
6 | Proteasome_Homo sapiens_hsa03050 | 2.46781986 |
7 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.38404736 |
8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.27686251 |
9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.26698799 |
10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.21691826 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.05002738 |
12 | Circadian rhythm_Homo sapiens_hsa04710 | 2.02125858 |
13 | RNA degradation_Homo sapiens_hsa03018 | 1.92190967 |
14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.90073540 |
15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.88293444 |
16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.84938331 |
17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.84128185 |
18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.75824140 |
19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.75320100 |
20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.74888763 |
21 | Mismatch repair_Homo sapiens_hsa03430 | 1.72907092 |
22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.70843729 |
23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.69270470 |
24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67461967 |
25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.67159472 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66099984 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63438534 |
28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.61486661 |
29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.61090565 |
30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.55743838 |
31 | RNA transport_Homo sapiens_hsa03013 | 1.55591069 |
32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.54989497 |
33 | Mineral absorption_Homo sapiens_hsa04978 | 1.53540318 |
34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51097549 |
35 | Phagosome_Homo sapiens_hsa04145 | 1.50964127 |
36 | Cell cycle_Homo sapiens_hsa04110 | 1.50456563 |
37 | Legionellosis_Homo sapiens_hsa05134 | 1.48842836 |
38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.48129058 |
39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.48086291 |
40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.46707542 |
41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46356703 |
42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.44661993 |
43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.43514981 |
44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42098121 |
45 | Lysine degradation_Homo sapiens_hsa00310 | 1.41477094 |
46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41407739 |
47 | Taste transduction_Homo sapiens_hsa04742 | 1.41232057 |
48 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38430324 |
49 | Measles_Homo sapiens_hsa05162 | 1.38015833 |
50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35685783 |
51 | DNA replication_Homo sapiens_hsa03030 | 1.32843736 |
52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.29717691 |
53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.25499529 |
54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.25333542 |
55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.23216158 |
56 | Malaria_Homo sapiens_hsa05144 | 1.18104444 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.18013355 |
58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17396092 |
59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15740737 |
60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.15530340 |
61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.15052191 |
62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14618334 |
63 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14185509 |
64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13880369 |
65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.12441038 |
66 | Phototransduction_Homo sapiens_hsa04744 | 1.12096545 |
67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11953975 |
68 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09048426 |
69 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09038344 |
70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.08640010 |
71 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07578836 |
72 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.06629112 |
73 | Homologous recombination_Homo sapiens_hsa03440 | 1.06357058 |
74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.04390631 |
75 | Olfactory transduction_Homo sapiens_hsa04740 | 1.03812697 |
76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03156796 |
77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02770832 |
78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.01796608 |
79 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.00128351 |
80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98893044 |
81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98537724 |
82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98377441 |
83 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.96997543 |
84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96752448 |
85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95199448 |
86 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.94331662 |
87 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94136114 |
88 | Base excision repair_Homo sapiens_hsa03410 | 0.91793329 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.91442334 |
90 | ABC transporters_Homo sapiens_hsa02010 | 0.90394824 |
91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89061249 |
92 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88751861 |
93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88074686 |
94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.86073500 |
95 | Morphine addiction_Homo sapiens_hsa05032 | 0.82915730 |
96 | Influenza A_Homo sapiens_hsa05164 | 0.81933210 |
97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.81568286 |
98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81457171 |
99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80088079 |
100 | Apoptosis_Homo sapiens_hsa04210 | 0.79295500 |
101 | GABAergic synapse_Homo sapiens_hsa04727 | 0.77371231 |
102 | Melanoma_Homo sapiens_hsa05218 | 0.77194148 |
103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76580012 |
104 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76473434 |
105 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.76098164 |
106 | Adherens junction_Homo sapiens_hsa04520 | 0.74718539 |
107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73143337 |
108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72838576 |
109 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72668983 |
110 | Purine metabolism_Homo sapiens_hsa00230 | 0.71527495 |
111 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69579125 |
112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69026792 |
113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68994623 |
114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68213131 |
115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68031523 |
116 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67479042 |
117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66538981 |
118 | Parkinsons disease_Homo sapiens_hsa05012 | 0.66249951 |
119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.66222954 |
120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66185619 |
121 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65744268 |
122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65569549 |
123 | Tight junction_Homo sapiens_hsa04530 | 0.65307882 |
124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63967357 |
125 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63540037 |
126 | Asthma_Homo sapiens_hsa05310 | 0.63408501 |
127 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62072752 |
128 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61151225 |
129 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60988075 |
130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60458913 |
131 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60388216 |
132 | Bile secretion_Homo sapiens_hsa04976 | 0.58339687 |
133 | Axon guidance_Homo sapiens_hsa04360 | 0.57962443 |
134 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57577167 |
135 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57238773 |
136 | Tuberculosis_Homo sapiens_hsa05152 | 0.57008334 |
137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56969639 |
138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55660257 |
139 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55255731 |
140 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54224522 |
141 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53392954 |
142 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53102094 |
143 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52656740 |
144 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.51708585 |
145 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51680669 |
146 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50053881 |
147 | Pertussis_Homo sapiens_hsa05133 | 0.49749360 |
148 | RNA polymerase_Homo sapiens_hsa03020 | 0.49691489 |
149 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49586508 |
150 | Salmonella infection_Homo sapiens_hsa05132 | 0.49513303 |
151 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49505545 |
152 | Platelet activation_Homo sapiens_hsa04611 | 0.47564321 |
153 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.47382108 |
154 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46276227 |
155 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45873168 |
156 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45086157 |
157 | Hepatitis C_Homo sapiens_hsa05160 | 0.44793012 |
158 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43862695 |
159 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42658630 |
160 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42413529 |
161 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42394115 |
162 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41816242 |
163 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41351419 |
164 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40044794 |
165 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37959353 |
166 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37394731 |
167 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36397360 |
168 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36103089 |